MUSCAT : Afflicted by Duchenne muscular dystrophy (DMD), Suleiman urgently requires Elevidys injections to stave off atrophy, muscle weakness, and paralysis.
In response to the pressing need for treatment, donations have poured in from all corners of the Sultanate, reflecting a heartening display of solidarity. The Ministry of Social Development’s Jood online platform has spearheaded a fundraising campaign to support Suleiman’s medical expenses.
The campaign has witnessed a remarkable response, with contributions totaling RO 69,532 out of the targeted RO100,000. As efforts continue to rally support for Suleiman’s cause, the importance of raising awareness about DMD and its debilitating effects remains paramount.
Duchenne muscular dystrophy is a genetic disorder characterized by progressive muscle degeneration, primarily affecting boys. Onset typically occurs in early childhood, with symptoms manifesting between ages 2 and 3. While DMD primarily impacts males, rare instances have been reported in females.
For all the latest news from Oman and GCC, follow us on Twitter, Instagram and LinkedIn, like us on Facebook and subscribe to our YouTube page, which is updated daily.
Read More
- ROP urges public to celebrate Oman National Day responsibly
- Oman issues new telecoms and IT law, renames regulator
- Oman’s CPA recovers RO 4,750 for consumers in Al Suwaiq vehicle dispute
- Oman marks National Day with economic gains, rising global competitiveness and major development projects
- HH Sayyid Theyazin calls for closer dialogue with businesses, simpler procedures in Oman





